TrialThe Journal of infectious diseases2009

Decreasing efficacy of antimalarial combination therapy in Uganda is explained by decreasing host immunity rather than increasing drug resistance.

Bryan Greenhouse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.